Vevye
My Prescription
Payment
Select pharmacy
$299.00
Print or send this coupon to your phone
AlbertsonsPowered byPay as little as $0 for Vevye
Works with your insurance. Enroll in the manufacturer's savings program in a few steps.
About Vevye
Drug Details
Cyclosporine eye drops, known as Vevye, are prescribed for the treatment of dry eyes in adults. These eye drops work by reducing inflammation, which enhances tear production and alleviates symptoms of dry eyes. As a preservative-free medication, Vevye typically begins to show effects after four weeks of consistent use. The recommended dosage is twice daily, approximately 12 hours apart. Some users might experience side effects such as changes in vision and mild irritation or a stinging sensation in the eyes following application. Always consult your healthcare provider before using this medication to ensure it is safe and appropriate for your condition.
Price history for Vevye
1 Bottle, 2ML of 0.1%
Average retail price for Vevye
Average SaveHealth price for Vevye
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Vevye dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 2ML of 0.1% | 1 Bottle | $776.75 | $776.75 |
| 2ML of 0.1% | 2 Bottles | $1,536.49 | $768.25 |
| 2ML of 0.1% | 3 Bottles | $2,296.24 | $765.41 |
Vevye FAQs
Vevye is used for the treatment of the signs and symptoms of dry eye disease.
Vevye and Restasis are both medications used to treat dry eye disease, but they differ in their active ingredients and mechanisms of action. Vevye contains the active ingredient cyclosporine A in a unique formulation, while Restasis also contains cyclosporine but in a different formulation. The specific formulation of Vevye may offer different benefits in terms of absorption or patient tolerance. Both medications aim to increase tear production and reduce inflammation in the eyes, but the choice between them may depend on individual patient response and physician recommendation.
As of the latest information available, Vevye is not approved for use in the United States. It is always recommended to consult with a healthcare professional or check with the FDA for the most current information regarding drug availability.
Vevye (cyclosporine ophthalmic solution) is an FDA-approved medication used to increase tear production in patients with dry eye disease. Its effectiveness can vary among individuals, but clinical studies have shown that it can significantly improve tear production and reduce symptoms of dry eye in many patients. It is important for patients to follow their healthcare provider's instructions and use the medication consistently for optimal results.
Yes, Vevye (varenicline solution) is known to have anti-inflammatory properties. It is used to reduce inflammation in the treatment of dry eye disease.